16236738

Source:http://linkedlifedata.com/resource/pubmed/id/16236738

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0085533, umls-concept:C0728747
pubmed:issue	16
pubmed:dateCreated	2005-10-20
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00004067, http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00005970
pubmed:abstractText	We present the combined results of two trials that compared adjuvant chemotherapy with or without concurrent trastuzumab in women with surgically removed HER2-positive breast cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/U10-CA-021115, http://linkedlifedata.com/resource/pubmed/grant/U10-CA-12027, http://linkedlifedata.com/resource/pubmed/grant/U10-CA-25224, http://linkedlifedata.com/resource/pubmed/grant/U10-CA-31946, http://linkedlifedata.com/resource/pubmed/grant/U10-CA-32102, http://linkedlifedata.com/resource/pubmed/grant/U10-CA-37377, http://linkedlifedata.com/resource/pubmed/grant/U10-CA-69651, http://linkedlifedata.com/resource/pubmed/grant/U10-CA-69974
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16236738-16236735, http://linkedlifedata.com/resource/pubmed/commentcorrection/16236738-16236745, http://linkedlifedata.com/resource/pubmed/commentcorrection/16236738-16467555, http://linkedlifedata.com/resource/pubmed/commentcorrection/16236738-16470950, http://linkedlifedata.com/resource/pubmed/commentcorrection/16236738-16470953
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/adriamycinol, http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1533-4406
pubmed:author	pubmed-author:BrownAnn MAM, pubmed-author:BryantJohnJ, pubmed-author:DakhilShaker RSR, pubmed-author:DavidsonNancy ENE, pubmed-author:FehrenbacherLouisL, pubmed-author:GeyerCharles ECEJr, pubmed-author:IngleJames NJN, pubmed-author:JenkinsRobert BRB, pubmed-author:KaufmanPeter APA, pubmed-author:KleinPamela MPM, pubmed-author:KuttehLeila ALA, pubmed-author:LingleWilma LWL, pubmed-author:MamounasEleftherios PEP, pubmed-author:MartinoSilvanaS, pubmed-author:PaikSoonmyungS, pubmed-author:PerezEdith AEA, pubmed-author:PisanskyThomas MTM, pubmed-author:RomondEdward HEH, pubmed-author:SumanVera JVJ, pubmed-author:SwainSandra MSM, pubmed-author:Tan-ChiuElizabethE, pubmed-author:VisscherDaniel WDW, pubmed-author:VogelVictor GVG, pubmed-author:WolmarkNormanN, pubmed-author:YothersGregG
pubmed:copyrightInfo	Copyright 2005 Massachusetts Medical Society.
pubmed:issnType	Electronic
pubmed:day	20
pubmed:volume	353
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1673-84
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:16236738-Adult, pubmed-meshheading:16236738-Antibodies, Monoclonal, pubmed-meshheading:16236738-Antibodies, Monoclonal, Humanized, pubmed-meshheading:16236738-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16236738-Breast Neoplasms, pubmed-meshheading:16236738-Chemotherapy, Adjuvant, pubmed-meshheading:16236738-Cyclophosphamide, pubmed-meshheading:16236738-Disease-Free Survival, pubmed-meshheading:16236738-Doxorubicin, pubmed-meshheading:16236738-Female, pubmed-meshheading:16236738-Heart Diseases, pubmed-meshheading:16236738-Humans, pubmed-meshheading:16236738-Mastectomy, pubmed-meshheading:16236738-Middle Aged, pubmed-meshheading:16236738-Paclitaxel, pubmed-meshheading:16236738-Proportional Hazards Models, pubmed-meshheading:16236738-Receptor, erbB-2, pubmed-meshheading:16236738-Recurrence, pubmed-meshheading:16236738-Survival Analysis
pubmed:year	2005
pubmed:articleTitle	Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
pubmed:affiliation	National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural